Luye Pharmaceutical submitted a marketing application for th...

Luye Pharmaceutical submitted a marketing application for the new drug LY03010, demonstrating its research and development capabilities in the field of central nervous system treatment. At the same time, the market share of long-acting paliperidone palmitate injections has been broadened, which is expected to enhance Luye Pharmaceutical's competitive position in the global market.